EDA and X-linked hypohidrotic ectodermal dysplasia: In an attempt to establish a molecular therapy for XLHED, we generated and studied a recombinant EDA1 replacement protein which was shown to prevent XLHED in Tabby mice [9,10], a well-characterized disease model [11], and mitigated the disorder in affected dogs [12,13,14].